Literature DB >> 8314147

Molecular cloning of differentially expressed genes in human epithelial ovarian cancer.

S C Mok1, K K Wong, R K Chan, C C Lau, S W Tsao, R C Knapp, R S Berkowitz.   

Abstract

A DNA-fingerprinting approach has been adapted to detect differentially expressed genes in human ovarian carcinoma. This method is based on the use of arbitrary primers to generate fingerprints from total RNA isolated from normal ovarian epithelial cells and ovarian carcinoma cells by polymerase chain reaction (PCR). Using this method, we cloned two cDNA fragments (DOC-1 and DOC-2) which were present in normal ovarian surface epithelial cells but consistently absent in all of the ovarian cancer cell lines from the differential display. In addition, we also identified a cDNA fragment (LF4.0) which is overexpressed in most of the tumor cell lines and tumor tissues in comparison to the normal ovarian surface epithelial cells. The differential expression of the genes in the tumor cell lines as well as in the tumor tissues was also confirmed by Northern analysis. The clone DOC-2, which is a 800-bp cDNA fragment, has one open reading frame suggesting that the gene may be translated. Assuming that this frame is the sense strand, we generated both sense and antisense riboprobe for in situ mRNA hybridization. Only the antisense DOC-2 riboprobe revealed a hybridization signal which was restricted to the human surface ovarian epithelium. The potential functional roles of these genes is now under investigation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8314147     DOI: 10.1006/gyno.1994.1040

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  50 in total

Review 1.  Differential screening technology in the service of ovarian biology.

Authors:  Adriano B Tavares; Eli Y Adashi
Journal:  Rev Endocr Metab Disord       Date:  2002-01       Impact factor: 6.514

Review 2.  Molecular genetics of ovarian cancer.

Authors:  A N Shelling; W Foulkes
Journal:  Mol Biotechnol       Date:  2001-09       Impact factor: 2.695

3.  Early genetic mechanisms underlying the inhibitory effects of endostatin and fumagillin on human endothelial cells.

Authors:  Chiara M Mazzanti; Anita Tandle; Dominique Lorang; Nick Costouros; David Roberts; Generoso Bevilacqua; Steven K Libutti
Journal:  Genome Res       Date:  2004-08       Impact factor: 9.043

4.  Goodpasture antigen-binding protein (GPBP) directs myofibril formation: identification of intracellular downstream effector 130-kDa GPBP-interacting protein (GIP130).

Authors:  Francisco Revert-Ros; Ernesto López-Pascual; Froilán Granero-Moltó; Jesús Macías; Richard Breyer; Roy Zent; Billy G Hudson; Anas Saadeddin; Fernando Revert; Raül Blasco; Carmen Navarro; Deborah Burks; Juan Saus
Journal:  J Biol Chem       Date:  2011-08-09       Impact factor: 5.157

5.  Intra- and interindividual variation in gene expression in human adipose tissue.

Authors:  Esther A van Beek; Arjen H Bakker; Philip M Kruyt; Marten H Hofker; Wim H Saris; Jaap Keijer
Journal:  Pflugers Arch       Date:  2006-10-24       Impact factor: 3.657

6.  Functional characterization of filamin a interacting protein 1-like, a novel candidate for antivascular cancer therapy.

Authors:  Mijung Kwon; Engy Hanna; Dominique Lorang; Mei He; John S Quick; Asha Adem; Christina Stevenson; Joon-Yong Chung; Stephen M Hewitt; Enrique Zudaire; Dominic Esposito; Frank Cuttitta; Steven K Libutti
Journal:  Cancer Res       Date:  2008-09-15       Impact factor: 12.701

7.  Disabled-2 heterozygous mice are predisposed to endometrial and ovarian tumorigenesis and exhibit sex-biased embryonic lethality in a p53-null background.

Authors:  Dong-Hua Yang; Zia Fazili; Elizabeth R Smith; Kathy Qi Cai; Andres Klein-Szanto; Cynthia Cohen; Ira R Horowitz; Xiang-Xi Xu
Journal:  Am J Pathol       Date:  2006-07       Impact factor: 4.307

8.  Filamin A interacting protein 1-like inhibits WNT signaling and MMP expression to suppress cancer cell invasion and metastasis.

Authors:  Mijung Kwon; Soo Jin Lee; Yarong Wang; Yevangelina Rybak; Alex Luna; Srilakshmi Reddy; Asha Adem; Brian T Beaty; John S Condeelis; Steven K Libutti
Journal:  Int J Cancer       Date:  2014-02-20       Impact factor: 7.396

9.  Type II transforming growth factor-beta receptor recycling is dependent upon the clathrin adaptor protein Dab2.

Authors:  Sumedha G Penheiter; Raman Deep Singh; Claire E Repellin; Mark C Wilkes; Maryanne Edens; Philip H Howe; Richard E Pagano; Edward B Leof
Journal:  Mol Biol Cell       Date:  2010-09-29       Impact factor: 4.138

10.  Quantitative proteomics identifies a Dab2/integrin module regulating cell migration.

Authors:  Anjali Teckchandani; Natalie Toida; Jake Goodchild; Christine Henderson; Julian Watts; Bernd Wollscheid; Jonathan A Cooper
Journal:  J Cell Biol       Date:  2009-07-06       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.